E
LUNG icon

Ergoteles’s Pulmonx LUNG Stock Holding History

Ergoteles’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,625
Closed -$597K – 1461
2021
Q4 		$597K Buy
+18,625
New +$680K 0.02% 576

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Ergoteles's LUNG Position: Q1 2022 in Review

Ergoteles sold out of Pulmonx (LUNG) in Q1 2022, closing a stake of 18,625 shares — an estimated $597K sold.

Ergoteles first reported a position in LUNG in Q4 2021 and held it in 1 quarter. The position peaked at $597K in Q4 2021. 109 funds tracked by Wall St. Rank hold LUNG as of Q1 2022.

  • Ergoteles reported no remaining Pulmonx position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 18,625 Pulmonx shares in Q1 2022, an estimated $597K.
  • Ergoteles first reported a position in Pulmonx in Q4 2021 and held it in 1 quarter.
  • Ergoteles's Pulmonx position peaked at $597K in Q4 2021.
  • 109 funds tracked by Wall St. Rank held Pulmonx as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.